Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects
- 31 March 2000
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 149 (1) , 91-97
- https://doi.org/10.1016/s0021-9150(99)00311-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosisNature, 1998
- Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidationThe Lancet, 1997
- Lewis A. Conner Memorial LectureCirculation, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarinNature Genetics, 1996
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.Journal of Clinical Investigation, 1995
- Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetesThe Lancet, 1995
- Atherosclerosis: Basic MechanismsCirculation, 1995
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoproteinFEBS Letters, 1991